Physician profile
Bhargav Mudda
NPI 1346501699
$40,256.35
in general payments reported to CMS, 2019-2025
20 companies · $668 in 2025
The $668 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,885 · 2020: $26K · 2021: $4,939 · 2022: $1,114 · 2023: $543 · 2024: $1,603 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,242 · Travel and Lodging: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,241.94 |
| Travel and Lodging | $572.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $26,097.10 | 2019-2021 | |
| Abbott Laboratories | $8,452.08 | 2019-2025 | Proclaim, Axium, Octrode |
| Boston Scientific Corporation | $1,781.23 | 2019-2025 | Intracept |
| Medtronic, INC. | $1,693.86 | 2021-2025 | Intellis Adaptivestim, Accurian |
| Vertiflex, INC. | $1,314.64 | 2019 | |
| Nevro Corp. | $214.24 | 2023-2024 | Senza |
| Globus Medical, INC. | $115.76 | 2025 | Senza |
| Spinal Simplicity, LLC | $112.33 | 2021 | |
| Foundation Fusion Solutions, LLC | $85.27 | 2021 | |
| Spr Therapeutics, INC | $78.74 | 2020-2023 | Sprint Pns System |
| Merz Pharmaceuticals, LLC | $60.68 | 2022-2023 | Xeomin |
| Lundbeck LLC | $55.14 | 2024-2025 | Vyepti |
| Relievant Medsystems, INC. | $43.64 | 2022-2023 | Intracept |
| Nalu Medical, INC. | $37.28 | 2024 | Nalu Neurostimulation System |
| Grt US Holding, INC. | $25.75 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $21.24 | 2023 | Evoke Scs |
| Biotronik Nro, INC. | $20.57 | 2024 | Prospera |
| Vertex Pharmaceuticals Incorporated | $17.60 | 2025 | |
| Mdd US Operations, LLC | $16.81 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhargav Mudda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.